Oragenics

+$0.01 (+3.12%) Today
-$0.0001 (-0.03%) As of 9:57 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Oragenics and other ETFs, options, and stocks.

About OGEN

Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of antibiotics and genetically engineered bacterial strains.

CEO
Michael O'Keefe Sullivan
Employees
5
Headquarters
Tampa, Florida
Founded
1996

OGEN Key Statistics

Market cap
38.43M
Price-Earnings ratio
—
Dividend yield
—
Average volume
474.86K
High today
$0.3451
Low today
$0.3201
Open price
$0.325
Volume
572.50K
52 Week high
$1.15
52 Week low
$0.2184

OGEN Earnings

-$0.08
-$0.05
-$0.03
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 12, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure